Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

REL, Mouse, Clone: 1E7, Abnova™

Mouse monoclonal antibody raised against partial recombinant REL.

Supplier:  Abnova Corporation MAB10516

Catalog No. 89-108-703


Only null left
Add to Cart

Description

Description

The REL gene encodes c-Rel, a transcription factor that is a member of the Rel/NFKB family, which also includes RELA (MIM 164014), RELB (604758), NFKB1 (MIM 164011), and NFKB2 (MIM 164012). These proteins are related through a highly conserved N-terminal region termed the 'Rel domain,' which is responsible for DNA binding, dimerization, nuclear localization, and binding to the NFKB inhibitor (MIM 164008) (Belguise and Sonenshein, 2007 [PubMed 18037997]).[supplied by OMIM

Specifications

Specifications

REL
Monoclonal
Unconjugated
ELISA (1:10000) Western Blot (1:500-1:2000) Immunohistochemistry (1:200-1:1000) Immunofluorescence (1:200-1:1000) The optimal working dilution should be determined by the end user.
REL
REL
Recombinant protein corresponding to human REL.
RUO
5966
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
IgG1
ELISA, Immunofluorescence, Immunohistochemistry, Western Blot
1E7
Mouse monoclonal antibody raised against partial recombinant REL.
In ascites (0.03% sodium azide)
C-Rel
Mouse
100 μL
Primary
Human, Mouse
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.